BLLN Stock Analysis: Buy, Sell, or Hold?
$103.95
2.83 (2.80%)
▲
5d:
+10.08%
30d:
+18.21%
90d:
+45.71%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When BLLN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BLLN shows positive signals but monitor for confirmation. Market pricing in 7.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BLLN shows positive signals but monitor for confirmation. Market pricing in 7.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$43.55
Based on 11.2% avg growth
INTRINSIC VALUE TODAY
$27.04
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLLN is currently trading at $103.95, which is considered extended relative to its 30-day fair value range of $86.58 to $100.86. From a valuation perspective, the stock is trading at a discount (Forward PE: 100.9) compared to its historical average (127.3). Remarkably, the market is currently pricing in an annual earnings decline of 7.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLLN is in a uptrend. Immediate support is located at $88.45, while resistance sits at $110.00.
Market Sentiment: BLLN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (12th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $117.71 (+13.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLLN is in a uptrend. Immediate support is located at $88.45, while resistance sits at $110.00.
Market Sentiment: BLLN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (12th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $117.71 (+13.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$86.58 -
$100.86
Company Quality Score
58/100
(HOLD)
Options IV Signal
12th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
67.3%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 12th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($117.71)
Trading Range Analysis
30-Day Trading Range
$86.58 -
$100.86
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$11.30
(10.9%)
Support & Resistance Levels
Support Level
$88.45
Resistance Level
$110.00
Current Trend
Uptrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
100.92
Wall Street Target
$117.71
(+13.2%)
Revenue Growth (YoY)
83.8%
Profit Margin
7.0%
Valuation Discount vs History
-7.5% cheaper
PE vs Historical
100.9 vs 127.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.5%
(market-implied from PE analysis)
1-Year Target
$96.15
(-8%)
2-Year Target
$88.94
(-14%)
3-Year Target
$82.27
(-21%)
3-Yr Target (if PE normalizes)
(PE: 101→127)
$103.77
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 100.9, Growth: 18.4%)
$172.50
(+66%)
Base:
(SPY PE: 21.8, Growth: 18.4%)
$37.23
(-64%)
Bear:
(PE: 18.5, Growth: 18.4%)
$31.64
(-70%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (184x PE), but valuation improves significantly next year (101x PE) as earnings recover.
Trailing PE: 183.85 | Current EPS (TTM): $0.55
Bull Case
$208.31
(+100%)
Analyst growth 87.3%, PE expands to 202.2
Base Case
$189.37
(+82%)
Market implied 87.3%, PE stable at 183.9
Bear Case
$68.76
(-34%)
Severe decline -20.0%, PE contracts to 156.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 100.9 to 127.3
Stabilization Target:
$131.12
(+26.1%)
PE Expansion Potential:
+26.1%
Share & Embed Analysis
Last updated: June 16, 2026 12:20 AM ET
Data refreshes hourly during market hours. Next update: 1:20 AM
Data refreshes hourly during market hours. Next update: 1:20 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLLN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 60 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 63 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$141 | 59 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |